Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Data up to Jan 2025
Total Citations Per Year
Abstract
References (48)
Matrix metalloproteinases: effectors of development and normal physiology
2000 • 1,236 citations
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
1996 • 1,131 citations
Evidence for Possible Involvement of 5-HT 2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
2000 • 668 citations
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
1997 • 582 citations
Increased plasma serotonin in primary pulmonary hypertension
1995 • 551 citations
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
2001 • 506 citations
Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-β 1 and Bone Morphogenetic Proteins
2001 • 453 citations
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
2001 • 450 citations
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
1999 • 427 citations
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
2000 • 403 citations
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
2000 • 373 citations
Serotonin 2B receptor is required for heart development
2000 • 357 citations
Expression of serotonin receptor mRNAs in blood vessels
1995 • 331 citations
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
2000 • 318 citations
A new role for an old molecule: serotonin as a mitogen
1997 • 253 citations
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.
1998 • 232 citations
5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension
2000 • 229 citations
Contribution of the 5-HT 1B Receptor to Hypoxia-Induced Pulmonary Hypertension
2001 • 217 citations
Anorexigens and Pulmonary Hypertension in the United States
2000 • 190 citations
5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways
2000 • 177 citations
Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion
1999 • 139 citations
High Plasma Serotonin Levels in Primary Pulmonary Hypertension
2000 • 137 citations
Ablation of Serotonin 5-HT 2B Receptors in Mice Leads to Abnormal Cardiac Structure and Function
2001 • 136 citations
Prostacyclin Receptor-dependent Modulation of Pulmonary Vascular Remodeling
2001 • 133 citations
Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor
1996 • 132 citations
Regression of Hypertrophied Rat Pulmonary Arteries in Organ Culture Is Associated With Suppression of Proteolytic Activity, Inhibition of Tenascin-C, and Smooth Muscle Cell Apoptosis
1999 • 125 citations
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
1999 • 115 citations
RS‐127445: a selective, high affinity, orally bioavailable 5‐HT2B receptor antagonist
1999 • 114 citations
Further evidence that 5‐HT‐induced relaxation of pig pulmonary artery is mediated by endothelial 5‐HT2B receptors
2000 • 89 citations
NPR-A–Deficient Mice Show Increased Susceptibility to Hypoxia-Induced Pulmonary Hypertension
1999 • 83 citations
Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture
1994 • 76 citations
5‐HT2B receptor‐mediated calcium release from ryanodine‐sensitive intracellular stores in human pulmonary artery endothelial cells
1996 • 71 citations
Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries.
1997 • 68 citations
Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?
1999 • 67 citations
EFFECT OF FENFLURAMINE ON 5‐HYDROXYTRYPTAMINE UPTAKE AND RELEASE BY RAT BLOOD PLATELETS
1975 • 65 citations
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis
2002 • 62 citations
EVE and beyond, retro and prospective insights
1999 • 58 citations
Anorectic Drugs and Pulmonary Hypertension from the Bedside to the Bench
2001 • 53 citations
Role of Vascular Smooth Muscle in the Development of High Altitude Pulmonary Hypertension: An Interspecies Evaluation
2001 • 46 citations
Miscellaneous Item
1997 • 44 citations
Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats.
2001 • 43 citations
Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia
1998 • 41 citations
Linking a serotonin transporter polymorphism to vascular smoothmuscle proliferation in patients with primary pulmonary hypertension
2001 • 35 citations
Linking a serotonin transporter polymorphism to vascular smoothmuscle proliferation in patients with primary pulmonary hypertension
2001 • 27 citations
Cellular and molecular mechanisms responsible for the pathogenesis of primary pulmonary hypertension
1999 • 21 citations
Effects of chronic dexfenfluramine treatment on pulmonary hemodynamics in dogs.
1996 • 16 citations
Problems of Pulmonary Hypertension in Children with Congenital Cardiac Defects
1988 • 16 citations
The identification of two new urinary metabolites of fenfluramine in man
1983 • 14 citations